Log in to search using one of your social media accounts:


HPV Vaccine Linked to Drop in Cases of Rare Childhood Disease

THURSDAY, Nov. 9, 2017 -- The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease, a new study suggests. It's believed that the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Anti-vaccine advocate Robert F. Kennedy Jr. said that President-elect Donald Trump asked him to lead a new government commission on vaccine safety. But science on this issue is already clear; numerous studies show that vaccines are safe and effective, and that serious side effects are rare. On Jan. 10, Kennedy met with the president-elect at Trump Tower, and later told reporters about the new commission. However, the Trump administration did not confirm that such a commission was in the works. A spokesperson for Trump said only that the president-elect was “exploring the possibility of forming a committee on autism,&...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Human papillomavirus (HPV) is the most common cause of cervical cancer worldwide, and Romania has the highest rate of cervical cancer in Europe. Sixty-five young Romanian women infected with HIV during early childhood and 25 control subjects were evaluated for the presence of cervical HPV infection and for cytologic abnormalities. HPV infection was evaluated longitudinally in 42 HIV-infected individuals. Overall 28/65 (43.1%) of HIV-infected and 8/25 (32.0%) of uninfected subjects were infected with HPV, and 21/65 (32.3%) and 6/25 (24%) had high-risk subtypes, respectively. In HIV-infected women, those maintaining or acqui...
Source: International Journal of STD and AIDS - Category: Global & Universal Authors: Tags: Original research articles Source Type: research
Key content An organised screening programme has reduced the incidence of cervical cancer in the UK. Cervical screening aims to detect and treat premalignant, low‐ or high‐grade disease. Oncogenic or high‐risk human papillomaviruses (HR‐HPV) account for over 99.7% of cervical cancer cases; the most common subtypes are HPV‐16, 18, 31, 33 and 45. HPV vaccination was introduced as part of the childhood vaccination programme in 2008 and will probably save 400 lives per year. HPV testing is useful: in triage of women with borderline or low‐grade cytology; as a test of cure after treatment, in the management of ...
Source: The Obstetrician and Gynaecologist - Category: OBGYN Authors: Tags: Review Source Type: research
By Stacy Simon The American Cancer Society is supporting a call-to-action from dozens of National Cancer Institute-designated Cancer Centers across the US urging action to increase vaccination against human papillomavirus (HPV). HPV vaccines protect against high-risk types of the virus that cause most cervical cancers. The virus is also linked to cancers of the vulva, vagina, penis, anus, and throat. Despite this, vaccination rates across the US remain low. According to the Centers for Disease Control and Prevention (CDC), only 40% of girls and 21% of boys in the US have received all 3 doses of the vaccine. The CDC recomme...
Source: American Cancer Society :: News and Features - Category: Cancer & Oncology Tags: Cervical Cancer Oral Cavity and Oropharyngeal Cancer Anal Cancer Vulvar Cancer Vaginal Cancer Source Type: news
Authors: Poh SS, Chua ML, Wee JT Abstract Current proposed mechanisms implicate both early and latent Epstein-Barr virus (EBV) infection in the carcinogenic cascade, whereas epidemiological studies have always associated nasopharyngeal carcinoma (NPC) with early childhood EBV infection and with chronic ear, nose, and sinus conditions. Moreover, most patients with NPC present with IgA antibody titers to EBV capsid antigen (VCA-IgA), which can precede actual tumor presentation by several years. If early childhood EBV infection indeed constitutes a key event in NPC carcinogenesis, one would have to explain the inabili...
Source: Chinese Journal of Cancer - Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research
Conclusion Despite their increased risk for HPV-related complication, a minority of childhood cancer survivors have initiated or completed HPV vaccination. Modifiable factors associated with vaccine outcomes were identified. Implications for Cancer Survivors HPV vaccination is a useful tool for cancer prevention in survivorship, and interventions to increase vaccine uptake are warranted.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research
Health authorities around the world, including WHO, recommend starting cervical screening at age 25 years or older, thus excluding young women from population screening.1 This guidance was developed on the basis of numerous investigations documenting high rates of human papillomavirus infection in the general population of young women, with very low rates of cervical cancer.2 Although human papillomavirus infection is common, occurring shortly after sexual debut, it is largely transient and asymptomatic.
Source: LANCET - Category: Journals (General) Authors: Tags: Comment Source Type: research
The objective of this study was to estimate the prevalence of and factors associated with HPV vaccine initiation and completion among females surviving childhood cancer. ProcedureOne‐hundred fourteen young adults and 230 mothers with daughters surviving childhood cancer completed surveys querying HPV vaccination history along with medical and sociodemographic factors potentially associated with vaccination outcomes. Vaccination rate differences by age necessitated analysis of outcomes by age group: 9–13 years (preadolescents), 14–17 years (adolescents), and 18–26 years (young adults). Multivariable logi...
Source: Pediatric Blood and Cancer - Category: Cancer & Oncology Authors: Tags: Research Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Childhood Cancer | General Medicine | Genital Warts | Human Papillomavirus (HPV) | Respiratory Medicine | Study | Vaccines